| Abstract: | South East Asia is experiencing a severe shortage of safe blood. The region collects only 7 million units a year but needs a total of 15 million units. This problem is worsened by inappropriate use of blood without separation into its components, with 80-85% of blood being used as whole blood. In addition, the Supreme Court in India has banned the use of blood from professional blood sellers because they were considered to be a high-risk group of HIV. Unscreened blood is also allowed to flourish in both Bangladesh and Pakistan because these countries do not have any national blood policy. Moreover, even with blood screening in India, hepatitis B and C are present because the virus is not tested in this country. In the screened blood in India, the seroprevalence of hepatitis B is 0.06-8.5% and that of hepatitis C is 1.2-3%. While in Islamabad, Pakistan, testing results showed that 8.1% of blood was infected with hepatitis C. Lastly, 5-10% of HIV infections in Southeast Asia are transfusion-induced. |
